LEP and type 2 diabetes mellitus: SB probiotics administration showed favorable results by decreasing the serum lipids and inflammation molecules associated with changes at the phylum, family, and genus levels of the gut microbial environment in leptin-resistant obese and type 2 diabetic mice; the modulation of gut microbiota composition was correlated with metabolic parameters [25,33].